Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pilief is a proprietary Ayurvedic formulation developed by Charak for the management of internal and external hemorrhoids (piles). Available in both oral tablet and topical ointment forms, Pilief contains a synergistic blend of traditional herbal ingredients—including Haritaki (Terminalia chebula), Neem (Azadirachta indica), Khadira (Acacia catechu), and Kumari (Aloe barbadensis)—that exhibit anti-inflammatory, analgesic, antiseptic, and astringent properties. The formulation helps reduce pile mass, control minor bleeding, alleviate pain and itching, and promote the healing of inflamed tissues. Additionally, the oral tablets support digestive health and act as a mild laxative to relieve constipation, which is a primary contributing factor to hemorrhoids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pilief.